Ali Cihat Aslan

Ali Cihat Aslan

Auto-generated profile, based on publicly available information

Ali Cihat Aslan

Viransehir State Hospital, Eye Clinic, Urfa, Turkey

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 August 2019 in Ocular Immunology and Inflammation
Verified
Journal Article
Closed access
BEBurak Erden
Burak Erden
AÇAkın Çakır
Akın Çakır
AAAli Cihat Aslan
Ali Cihat Aslan
SBSelim Bölükbaşı
Selim Bölükbaşı
MEMustafa Nuri Elçioğlu
Mustafa Nuri Elçioğlu
Purpose: To evaluate the efficacy and safety of posterior 40 mg subtenon triamcinolone acetonide (PST) injection in treating Irvine-Gass syndrome. Methods: The retrospective study included 21 patients (mean age: 76 ± 8.2) with a treatment-naïve eye subjected to topical anesthesia and injection of 40 mg/ml triamcinolone via a blunt tip SubTenon cannula through a single inferonasal peritomy. Best corrected visual acuity (BCVA; logMAR), intraocular pressure (IOP), biomicroscopic and funduscopic findings, and optical coherence tomography (OCT) measurements were recorded. Results: Baseline central macular thickness decreased from 431 ± 136 µm to 300 ± 67 µm (1st month; p = .002), to 292 ± 56 µm (3rd month; p = .002), and to 299 ± 66 µm (6th month; p = .005). Mean BCVA increased from 0.71 ± 0.23 to 0.27 ± 0.11, 0.19 ± 0.06, and 0.24 ± 0.17, respectively (all visits; p < 0.001). Mean IOP values did not change significantly (p = .12). Conclusion: PST injection is an effective and safe treatment for Irvine-Gass syndrome.

1 September 2019 in European Archives of Medical Research
Verified
Journal Article
Closed access
BEBurak Erden
Burak Erden
AÇAkın Çakır
Akın Çakır
SBSelim Bölükbaşı
Selim Bölükbaşı
AAAli Cihat Aslan
Ali Cihat Aslan
MEMustafa Nuri Elçioğlu
Mustafa Nuri Elçioğlu